Acacia Subsidiary Acquires Patent on Stent Graft Technology

Loading...
Loading...
Acacia Research Corp
ACTG
announced today that a subsidiary has acquired a patent for stent graft technology. “Acacia continues to increase the number of patent portfolios we control in the medical device and diagnostics sectors,” commented Paul Ryan, CEO. “Acacia is expanding its presence as a leader in patent licensing for both the technology and medical technology sectors.” ABOUT ACACIA RESEARCH CORPORATION Acacia Research Corporation's subsidiaries partner with inventors and patent owners, license the patents to corporate users, and share the revenue. Acacia Research Corporation's subsidiaries control over 200 patent portfolios, covering technologies used in a wide variety of
See full press release
Market News and Data brought to you by Benzinga APIs
Posted In: NewsGuidanceM&A
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...